Home > Publikationen > 2015

2015

Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia.
Steinbach D, Bader P, Willasch A, Bartholomae S, Debatin KM, Zimmermann M, Creutzig U, Reinhardt D, Gruhn B.
Clinical cancer research : an official journal of the American Association for Cancer Research 2015; 2162015Mar15: 1353-9 >>
Artikel auf PubMed lesen

PLEKHM1 regulates Salmonella-containing vacuole biogenesis and infection.
McEwan DG, Richter B, Claudi B, Wigge C, Wild P, Farhan H, McGourty K, Coxon FP, Franz-Wachtel M, Perdu B, Akutsu M, Habermann A, Kirchof A, Helfrich MH, Odgren PR, Van Hul W, Frangakis AS, Rajalingam K, Macek B, Holden DW, Bumann D, Dikic I.
Cell host & microbe 2015; 1712015Jan14: 58-71 >>
Artikel auf PubMed lesen

PLEKHM1 regulates autophagosome-lysosome fusion through HOPS complex and LC3/GABARAP proteins.
McEwan DG, Popovic D, Gubas A, Terawaki S, Suzuki H, Stadel D, Coxon FP, Miranda de Stegmann D, Bhogaraju S, Maddi K, Kirchof A, Gatti E, Helfrich MH, Wakatsuki S, Behrends C, Pierre P, Dikic I.
Molecular cell 2015; 5712015Jan8: 39-54 >>
Artikel auf PubMed lesen

Prediction of the pathogenicity of antithrombin sequence variations by in silico methods.
Luxembourg B, D'Souza M, Körber S, Seifried E.
Thrombosis research 2015; 13522015Feb: 404-9 >>
Artikel auf PubMed lesen

RAB3GAP1 and RAB3GAP2 modulate basal and rapamycin-induced autophagy.
Spang N, Feldmann A, Huesmann H, Bekbulat F, Schmitt V, Hiebel C, Koziollek-Drechsler I, Clement AM, Moosmann B, Jung J, Behrends C, Dikic I, Kern A, Behl C.
Autophagy 2015; 10122014: 2297-309 >>
Artikel auf PubMed lesen

The inward rectifier potassium channel Kir2.1 is expressed in mouse neutrophils from bone marrow and liver.
Masia R, Krause DS, Yellen G.
American journal of physiology. Cell physiology 2015; 30832015Feb1: C264-76 >>
Artikel auf PubMed lesen

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial.
Schetelig J, Schaich M, Schäfer-Eckart K, Hänel M, Aulitzky WE, Einsele H, Schmitz N, Rösler W, Stelljes M, Baldus CD, Ho AD, Neubauer A, Serve H, Mayer J, Berdel WE, Mohr B, Oelschlägel U, Parmentier S, Röllig C, Kramer M, Platzbecker U, Illmer T, Thiede C, Bornhäuser M, Ehninger G, .
Leukemia 2015; 2952015May: 1060-8 >>
Artikel auf PubMed lesen

Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.
Davis H, Irshad S, Bansal M, Rafferty H, Boitsova T, Bardella C, Jaeger E, Lewis A, Freeman-Mills L, Giner FC, Rodenas-Cuadrado P, Mallappa S, Clark S, Thomas H, Jeffery R, Poulsom R, Rodriguez-Justo M, Novelli M, Chetty R, Silver A, Sansom OJ, Greten FR, Wang LM, East JE, Tomlinson I, Leedham SJ.
Nature medicine 2015; 2112015Jan: 62-70 >>
Artikel auf PubMed lesen

Direct observation of mobility state transitions in RNA trajectories by sensitive single molecule feedback tracking.
Spille JH, Kaminski TP, Scherer K, Rinne JS, Heckel A, Kubitscheck U.
Nucleic acids research 2015; 4322015Jan: e14 >>
Artikel auf PubMed lesen

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation.
Mian AA, Rafiei A, Haberbosch I, Zeifman A, Titov I, Stroylov V, Metodieva A, Stroganov O, Novikov F, Brill B, Chilov G, Hoelzer D, Ottmann OG, Ruthardt M.
Leukemia 2015; 2952015May: 1104-14 >>
Artikel auf PubMed lesen

Logo: Paul-Ehrlich-Institut Logo: Georg Speyer Haus Logo: Goethe Universität Logo: Max-Planck-Institut Logo: DRK Blutspendedienst